Article Text

Download PDFPDF
Pelvic Exenterations for Advanced and Recurrent Endometrial Cancer: Clinical Outcomes of 40 Patients
  1. Ana-Maria Schmidt, MD,
  2. Patrick Imesch, MD,
  3. Daniel Fink, MD and
  4. Herwig Egger, MD
  1. * Department of Gynecology, University Hospital Zurich, Zurich, Switzerland; and
  2. Department of Obstetrics and Gynecology, General Hospital Neumarkt, Germany.
  1. Address correspondence and reprint requests to Ana-Maria Schmidt, MD, Department of Gynecology, University Hospital of Zurich, Frauenklinikstrasse 10, CH-8091 Zurich, Switzerland. Email: ana-maria.schmidt{at}usz.ch.

Abstract

Objective The aim of this study was to analyze the clinical experience and outcome of patients who have undergone pelvic exenteration for primary advanced or recurrent endometrial cancer.

Methods We analyzed the medical records of 40 women who underwent pelvic exenteration to treat primary advanced or recurrent endometrial cancer.

Results Pelvic exenteration was performed in 40 patients with primary advanced or recurrent endometrial cancer. Three patients (8%) underwent a primary exenteration, and 37 patients (92%) underwent a secondary exenteration. A total exenteration, anterior exenteration, and posterior exenteration was performed in 85%, 5%, and 10% of patients, respectively.

In 31 cases, exenteration was performed with a curative aim, and in 9 cases, exenteration was performed with a palliative aim. The overall survival rates were 61.4% at 5 years and 51.1% at 10 years. For the 31 patients who underwent pelvic exenteration with a curative aim, the overall survival rates were higher than those for the entire study population and were 72.6% at 5 years and 59.4% at 10 years. For the 9 patients who underwent a palliative exenteration, the overall survival rates were 19.1% at 5 years and 0% at 10 years. This is to the best of our knowledge the biggest study of pelvic exenteration in patients with endometrial cancer.

Conclusions Our data show that pelvic exenterations are a valid therapeutic option with long-term survival in select patients.

  • pelvic exenteration
  • endometrial cancer
  • survival
  • radical surgery

Statistics from Altmetric.com

Supplementary materials

Related Data

Footnotes

  • The authors declare no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.